Regenerative Approach for Bursitis
- Written by
- StemCell Longevita Editorial Team
- Medically reviewed by
- Prof. Dr. Erdal Karaöz TeamProfessor of Histology and Embryology · Medical Director, Center for Regenerative Medicine
- Last reviewed
- Next scheduled review
How we evaluate evidence · Conflict-of-interest disclosure · Editorial standards
Advanced mesenchymal regenerative medicine application to reduce bursal inflammation, restore joint mobility, and provide lasting relief from chronic bursitis without surgery.
Can stem cell therapy help bursitis?
Mesenchymal stem cell and PRP therapies are not approved treatments for bursitis. Controlled evidence in this indication is limited. Established management — activity modification, physiotherapy, ice, non-steroidal medication, corticosteroid injection where appropriate, and treatment of any underlying joint or tendon pathology — remains the evidence-based path. Regenerative options here are considered only alongside a specialist plan.
Key facts
- Approval status
- Not approved for bursitis
- Evidence
- Limited controlled trials in bursitis specifically
- Standard care
- Activity modification, PT, NSAIDs, steroid injection when indicated
What we know
- Most bursitis responds to activity modification, rehabilitation and time; injection is reserved for persistent cases.
What remains uncertain
- Whether MSC or PRP injection provides benefit over corticosteroid injection or conservative care.
Medically reviewed questions
This summary is general medical information, not medical advice, and not a promise of benefit. Figures are quoted ranges, confirmed in writing after a medical review.
Medically reviewed by: Prof. Dr. Erdal Karaöz · Last updated: · Editorial and evidence policy
Evidence at a glance — Bursitis
A plain summary of what the published research does and does not show for this condition. It is written to the same standard whether the evidence is strong or weak.
- Human studies available?
- Limited
- Randomised trials?
- None identified
- Main outcomes studied
- Pain
- Range of motion
- Long-term evidence
- Very limited
- Regulatory approval for this indication
- United States (FDA): No FDA-approved mesenchymal stem cell product for this indication. The FDA has issued consumer warnings about unapproved stem cell products.
- European Union (EMA): No EMA-authorised mesenchymal stem cell medicine for this indication.
- United Kingdom (MHRA): No MHRA-authorised mesenchymal stem cell medicine for this indication.
- Türkiye (Ministry of Health): In Türkiye, cell therapies are delivered only inside Ministry of Health–licensed centres under the regenerative medicine / advanced therapy regulations, as clinical research or individual (exceptional) use — not as an approved routine treatment for this indication.
- Role at our centre
- Research context — considered only where standard care is exhausted or unsuitable, and never as a replacement for it
What kind of evidence exists
- Mechanism (laboratory): Documented
- Animal / preclinical: Documented
- Early human (phase 1/2, uncontrolled): Documented
- Controlled human (randomised or sham-controlled): Not established
- Regulatory approval: Not established
Sources
- Systematic reviews and meta-analyses — Bursitis — PubMed
- Randomised controlled trials — Bursitis — PubMed
- Registered MSC trials — Bursitis — ClinicalTrials.gov
- FDA — Consumer alert on regenerative medicine therapies — U.S. Food and Drug Administration, 2024
- Advanced therapy medicinal products: overview — European Medicines Agency, 2025
- ISSCR Guidelines for Stem Cell Research and Clinical Translation — International Society for Stem Cell Research, 2021
- ISSCR Patient Handbook on Stem Cell Therapies — International Society for Stem Cell Research, 2020
Source links open filtered searches of PubMed and ClinicalTrials.gov plus regulator and professional-society pages, so you can read the current evidence yourself rather than a selected extract.
This summary is general information about the evidence base, not medical advice and not a promise of benefit. Whether any treatment is appropriate for you can only be decided after a medical review of your records.
What is Bursitis and How Can Stem Cells Help?
Bursitis is the inflammation of the bursae — small, fluid-filled sacs that cushion the bones, tendons, and muscles near your joints. When these sacs become inflamed, they cause pain, stiffness, and limited range of motion, most commonly affecting the shoulders, hips, elbows, and knees.
Traditional treatments such as corticosteroid injections and anti-inflammatory medications provide temporary relief but do not address the underlying tissue damage. Chronic or recurring bursitis often leads to significant functional limitations and reduced quality of life.
Mesenchymal stem cell (MSC) therapy offers a regenerative approach by targeting the root cause of bursal inflammation. MSCs modulate the immune response, reduce chronic inflammation, and promote the healing of damaged surrounding tissues for more lasting results.
Expert Regenerative Care
Specialized bursitis treatment protocols
Our medical team develops personalized treatment protocols based on the specific type and severity of your bursitis, ensuring targeted delivery of MSCs to the affected bursa and surrounding tissues.
Using advanced imaging guidance, we deliver stem cells precisely to the inflamed area, maximizing therapeutic effect while minimizing discomfort during the procedure.
Benefits of Regenerative Approach for Bursitis
Discover how regenerative medicine can help resolve chronic bursitis and restore your joint function without surgery.
Reduced Inflammation
MSCs release potent anti-inflammatory factors that calm chronic bursal inflammation and prevent recurrence.
Pain Relief
Stem cells modulate pain signaling pathways, providing significant and lasting pain reduction without steroids.
Tissue Regeneration
MSCs promote repair of damaged tendons, ligaments, and soft tissues surrounding the affected bursa.
Restored Mobility
By resolving inflammation and repairing tissue damage, regenerative approaches supports restore full joint range of motion.
How Stem Cells Work for Bursitis
Mesenchymal regenerative medicine approach for bursitis addresses the chronic inflammation of the bursal sacs that cushion joints. Clinical studies suggest MSCs can reduce bursal inflammation, promote tissue repair, and restore normal joint mechanics by targeting the underlying causes of persistent bursitis.
MSCs release potent anti-inflammatory mediators including prostaglandin E2 and interleukin-1 receptor antagonist that directly suppress the chronic inflammatory cascade within the inflamed bursa. This targeted anti-inflammatory action provides relief beyond what conventional treatments typically achieve.
Stem cells promote the regeneration of damaged bursal tissue by stimulating synovial cell proliferation and restoring the normal production of lubricating fluid. Clinical studies suggest this tissue repair helps the bursa regain its protective cushioning function between bones, tendons, and muscles.
MSC therapy modulates the local immune response by regulating T-cell and macrophage activity in the affected area. This immunomodulation helps break the cycle of chronic inflammation that perpetuates recurrent bursitis episodes.
Research indicates that MSCs secrete growth factors that promote the repair of adjacent tendons and soft tissues often involved in bursitis conditions. By addressing surrounding tissue damage, stem cells help resolve contributing biomechanical factors that lead to bursal irritation.
Who Is a Good Candidate?
Eligibility for regenerative medicine approach in bursitis is assessed through clinical examination, imaging studies, and evaluation of treatment history. Our specialists identify patients with chronic or recurrent bursitis who are most likely to benefit from regenerative intervention.
Ideal Candidates
- Patients with chronic bursitis lasting more than three months despite conventional treatments
- Individuals with recurrent bursitis episodes in the shoulder, hip, knee, or elbow
- Patients who have not responded adequately to rest, physical therapy, or corticosteroid injections
- Those with imaging-confirmed bursal thickening or persistent fluid accumulation
- Active individuals whose bursitis significantly limits work or recreational activities
May Not Be Suitable
- Patients with septic bursitis requiring antibiotic treatment or surgical drainage
- Individuals with bursitis caused by untreated gout or crystal arthropathy
- Patients with underlying structural deformities requiring surgical correction
- Those with active systemic infections or uncontrolled inflammatory conditions
What Results Can You Expect?
Recovery from regenerative medicine approach for bursitis tends to be relatively rapid compared to other musculoskeletal conditions, as bursal tissue responds well to regenerative treatment. Results vary based on the affected location and chronicity of the condition.
Initial Recovery
Mild soreness at the injection site. Some temporary increase in local swelling may occur. Activity modification and avoidance of aggravating movements are recommended during this initial period.
Early Improvements
Noticeable reduction in bursal pain and swelling as anti-inflammatory effects take hold. Many patients report improved comfort during movements that previously triggered bursitis symptoms.
Progressive Results
Continued improvement in joint function and further reduction in pain. Patients typically resume normal activities with significantly less discomfort. Bursal tissue repair progresses steadily.
Optimal Results
Peak therapeutic benefits with substantial pain relief and restored joint function. Most patients return to full activity levels including work and exercise without significant bursitis symptoms.
Long-Term Benefits
Sustained symptom relief with reduced risk of recurrence. The regenerated bursal tissue provides improved long-term joint protection. Ongoing activity modifications may help maintain results.
Individual results vary. These timelines are based on clinical observations and are not guaranteed outcomes. Your specialist will provide personalized expectations during your consultation.
Your Bursitis Care Process
Our comprehensive treatment protocol is designed to maximize therapeutic outcomes while ensuring your comfort throughout the process.
Step 1: Medical Evaluation
Comprehensive assessment of your bursitis including imaging studies and medical history review to develop a personalized care plan.
Step 2: Pre-Treatment Consultation
Detailed discussion with our medical team about the procedure, expected outcomes, and a personalized treatment timeline.
Step 3: Cell Preparation
Preparation of high-quality umbilical cord-derived mesenchymal stem cells in our certified laboratory under strict quality controls.
Step 4: Targeted Administration
Image-guided injection of MSCs directly into the inflamed bursa and surrounding affected tissues for maximum therapeutic effect.
Step 5: Follow-Up Care
Ongoing monitoring and follow-up consultations to track your healing progress and optimize recovery outcomes.
What's Included in Your approach
- Comprehensive medical evaluation and imaging
- Personalized treatment protocol
- High-quality umbilical cord-derived MSCs
- Image-guided injection procedure
- Post-treatment monitoring
- Follow-up consultations
- Airport transfer and accommodation assistance
- Dedicated patient coordinator
Safe & Proven
Clinically validated approach
Our bursitis treatment uses umbilical cord-derived MSCs that are immunoprivileged, carrying minimal risk of rejection. The procedure is minimally invasive with patients typically resuming normal activities within days.
Patient Experiences
Real outcomes from patients who chose regenerative medicine at StemCell Longevita Istanbul
"My orthopaedic surgeon in Munich said I'd need a new knee within a year. After regenerative medicine in Istanbul, that was two years ago and I still don't need it."
"I spent years managing pain instead of living. The treatment in Turkey gave me my active life back — something I didn't think was possible at my age."
Frequently Asked Questions About Bursitis Treatment
Watch Our Patient Stories & Expert Insights
See real results and hear from our medical team about stem cell therapy treatments, procedures, and patient outcomes.
All Regenerative Medicine Applications
Explore our comprehensive range of regenerative medicine applications for various conditions. Click any option to learn more.
Related Articles
Explore our in-depth research articles and guides on related treatments and therapies.
Spinal Cord Injury Rehabilitation with Stem Cells
Learn about advanced regenerative medicine applications that are supporting patients with spinal cord injuries in regaining sensation and mobility through physician-directed protocols.
Read ArticleUnderstanding Regenerative Medicine: A Complete Guide
A comprehensive overview of stem cell therapy, including types of stem cells, care processes, safety considerations, and what patients can expect during their wellness journey.
Read ArticleComplete Guide to Stem Cells and Their Types
Explore the different types of stem cells - adult, fetal, embryonic, and cord blood - their unique characteristics, therapeutic applications, and how they're advancing regenerative medicine.
Read ArticleHow Much Does This Cost Worldwide?
Compare this regenerative medicine costs at StemCell Longevita versus clinics in other countries.
| Country | Typical Cost |
|---|---|
| United States | $15,000 – $25,000 |
| United Kingdom | £12,000 – £20,000 |
| Germany | €15,000 – €25,000 |
| South Korea | $12,000 – $20,000 |
| StemCell Longevita (Turkey) | From £5,900 |
Prices based on market research of comparable stem cell clinics offering umbilical cord-derived MSC treatments (2025-2026). Actual prices vary by clinic, cell count, and condition.
Related clinical questions
Where this page sits in the wider picture.